We are live on !
Find out more
Emerald Acquisition Portfolio holdings
AUM
$51.8B
Turnover
12.96%
This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.8B
AUM Growth
-$5.97B
(-10%)
Cap. Flow
-$8.46B
Cap. Flow % of AUM
Cap. Flow %
-16.35%
Top 10 Holdings %
Top 10 Hldgs %
10.38%
Holding
3,194
New
200
Increased
788
Reduced
1,868
Closed
214
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KeyCorp
KEY
|
+$59.1M |
| 2 |
IHS Markit Ltd. Common Shares
INFO
|
+$56.2M |
| 3 |
Du Pont De Nemours E I
DD
|
+$54M |
| 4 |
Alibaba
BABA
|
+$47.2M |
| 5 |
McKesson
MCK
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC CORPORATION
EMC
|
+$142M |
| 2 |
Johnson & Johnson
JNJ
|
+$133M |
| 3 |
Wells Fargo
WFC
|
+$131M |
| 4 |
TSMC
TSM
|
+$120M |
| 5 |
Corning
GLW
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.36% |
| 2 | Healthcare | 13.13% |
| 3 | Technology | 12.22% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2126
Stratasys
SSYS
$598M
| $918K | ﹤0.01% |
38,069
+35,931
| +1,681% | +$783K |
2016 Q2
1 quarter
|
|
2127
Lindblad Expeditions
LIND
$2.31B
| $917K | ﹤0.01% |
101,940
-1,300
| -1% | -$12.2K |
2016 Q2
1 quarter
|
|
2128
Ryerson Holding Corp
RYZ
$1.46B
| $916K | ﹤0.01% |
81,100
+74,400
| +1,110% | +$1.01M |
2016 Q2
1 quarter
|
|
|
BNFT
2129
DELISTED
Benefitfocus, Inc.
BNFT
| $916K | ﹤0.01% |
22,945
-11,965
| -34% | -$491K |
2016 Q2
1 quarter
|
|
|
CYOU
2130
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $915K | ﹤0.01% |
33,920
| – | – |
2016 Q2
1 quarter
|
|
2131
Regional Management Corp
RM
$315M
| $909K | ﹤0.01% |
+42,000
| New | +$818K |
2016 Q3
0 quarters
|
|
|
RSO
2132
DELISTED
Resource Capital Corp.
RSO
| $907K | ﹤0.01% |
70,776
+13,703
| +24% | +$178K |
2016 Q2
1 quarter
|
|
2133
Insulet
PODD
$10.3B
| $906K | ﹤0.01% |
+22,110
| New | +$874K |
2016 Q3
0 quarters
|
|
2134
Belden
BDC
$4.04B
| $903K | ﹤0.01% |
13,085
-8,015
| -38% | -$557K |
2016 Q2
1 quarter
|
|
2135
FB Financial Corp
FBK
$2.65B
| $900K | ﹤0.01% |
+44,593
| New | +$916K |
2016 Q3
0 quarters
|
|
|
GST
2136
DELISTED
Gastar Exploration Inc.
GST
| $900K | ﹤0.01% |
1,065,360
| – | – |
2016 Q2
1 quarter
|
|
2137
ANI Pharmaceuticals
ANIP
$1.69B
| $897K | ﹤0.01% |
13,519
| – | – |
2016 Q2
1 quarter
|
|
2138
GameStop
GME
$12.8B
| $894K | ﹤0.01% |
129,656
-274,780
| -68% | -$2M |
2016 Q2
1 quarter
|
|
2139
MasterCraft Boat Holdings
MCFT
$494M
| $892K | ﹤0.01% |
78,235
+36,507
| +87% | +$420K |
2016 Q2
1 quarter
|
|
|
RFP
2140
DELISTED
Resolute Forest Products Inc.
RFP
| $891K | ﹤0.01% |
188,258
-14,400
| -7% | -$78.5K |
2016 Q2
1 quarter
|
|
2141
DELISTED
Dominion Diamond Corporation
DDC
| $891K | ﹤0.01% |
91,500
-3,500
| -4% | -$31.4K |
2016 Q2
1 quarter
|
|
2142
Nektar Therapeutics
NKTR
$1.32B
| $890K | ﹤0.01% |
3,456
-314
| -8% | -$80.8K |
2016 Q2
1 quarter
|
|
2143
ScottsMiracle-Gro
SMG
$3.44B
| $890K | ﹤0.01% |
10,687
+7,534
| +239% | +$594K |
2016 Q2
1 quarter
|
|
2144
DELISTED
Mattersight Corp.
MATR
| $888K | ﹤0.01% |
211,448
+18,500
| +10% | +$72.6K |
2016 Q2
1 quarter
|
|
2145
Enpro
NPO
$5.66B
| $887K | ﹤0.01% |
15,602
-13,086
| -46% | -$672K |
2016 Q2
1 quarter
|
|
2146
Trupanion
TRUP
$1.31B
| $887K | ﹤0.01% |
52,533
+12,582
| +31% | +$193K |
2016 Q2
1 quarter
|
|
2147
Twilio
TWLO
$39B
| $884K | ﹤0.01% |
+13,735
| New | +$686K |
2016 Q3
0 quarters
|
|
2148
Calix
CALX
$2.32B
| $883K | ﹤0.01% |
120,166
-19,600
| -14% | -$147K |
2016 Q2
1 quarter
|
|
2149
Koppers
KOP
$771M
| $881K | ﹤0.01% |
27,375
-44,134
| -62% | -$1.39M |
2016 Q2
1 quarter
|
|
2150
Tandem Diabetes Care
TNDM
$1.19B
| $880K | ﹤0.01% |
11,490
-1,257
| -10% | -$91.7K |
2016 Q2
1 quarter
|
|
Similar funds
ACN
Emerald Acquisition's Q3 2016 Portfolio in Review
As of Q3 2016, Emerald Acquisition held 3,194 positions worth $51.8B, down 10% from $57.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Emerald Acquisition withdrew a net $8.46B in Q3 2016, closing 214 positions and reducing 1,868 holdings. Its most notable exit was EMC CORPORATION, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Emerald Acquisition opened a new position in Novo Nordisk worth $13.9M.
- Emerald Acquisition's largest Q3 2016 buy was Novo Nordisk: 666,610 shares worth $13.9M.
- Emerald Acquisition added most to KeyCorp in Q3 2016, an estimated $59.1M increase.
- Emerald Acquisition's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $133M.
- Emerald Acquisition fully exited EMC CORPORATION in Q3 2016, selling an estimated $142M.
- Emerald Acquisition's ten largest holdings make up 10% of its $51.8B portfolio in Q3 2016.
- Emerald Acquisition opened 200 new positions and closed 214 in Q3 2016.
- Emerald Acquisition's portfolio value fell 10% quarter-over-quarter to $51.8B.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.